Clinical Trials Logo

Filter by:
NCT ID: NCT03539198 Terminated - Clinical trials for Head and Neck Cancer

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Start date: July 3, 2018
Phase:
Study type: Observational

This study observes the clinical efficacy of combining proton SBRT with PD-1 blockade immunotherapy in both the locoregionally recurrent and metastatic settings.

NCT ID: NCT03538795 Terminated - Stroke Clinical Trials

Brain Stimulation and Rehabilitation for Adults With Chronic, Severe Arm Motor Impairment After Stroke

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

This pilot study will examine a combination therapy for adults with chronic, severe motor impairment of an arm after stroke. The intervention will combine brain stimulation with physical rehabilitation of the arm on the side of the body more-affected by stroke.

NCT ID: NCT03538444 Terminated - Chronic Pain Clinical Trials

Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder

ArTMS
Start date: September 28, 2018
Phase: N/A
Study type: Interventional

This double-blind, randomized, controlled trials will investigate the effect of accelerated, repeated transcranial magnetic stimulation on opiate craving and perceived pain .

NCT ID: NCT03538015 Terminated - Clinical trials for Hypoglycemia Unawareness

Carvedilol in Treating Hypoglycemia Unawareness

Start date: April 22, 2019
Phase: Phase 2
Study type: Interventional

Type 1 diabetes mellitus (T1DM) can lead to cardiovascular, renal and neurological complications if left poorly-controlled over prolonged periods of time. However, lowering glycemic goals for diabetic patients increases their risk for hypoglycemia exposure. Hypoglycemia is associated with symptoms such as heart palpitations, fatigue, shakiness, anxiety, confusion, and blurred vision. Recurrent hypoglycemia leads to impairment of the body's autonomic and symptomatic responses to this condition, and can result in loss of awareness in the patient of the hypoglycemic state. Repeated incidences of hypoglycemia from loss of this awareness can result in even more hypoglycemic episodes and more severe outcomes, such as loss of consciousness, accidents, hospitalization and even death if left untreated. The aim of this study is to investigate whether adrenergic blockade through the use of low-dose carvedilol treatment can improve hypoglycemia awareness and the counterregulatory hormone responses to hypoglycemia in T1DM patients with impaired awareness of hypoglycemia.

NCT ID: NCT03537547 Terminated - Depression Clinical Trials

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Start date: May 4, 2018
Phase: Phase 4
Study type: Interventional

This study aims to determine whether the GeneSight Psychotropic test can result in better treatment outcomes for patients with treatment-naive major depressive disorder

NCT ID: NCT03537534 Terminated - Dysuria Clinical Trials

Intraurethral Lidocaine After Endourology Procedures

Start date: April 15, 2018
Phase: Phase 3
Study type: Interventional

Many urological conditions are diagnosed and treated with the use of endourology procedures. Unfortunately, dysuria is a common patient complaint following these procedures. Intraurethral lidocaine instillation is regularly used prior to office-based endourology procedures to alleviate dysuria, as well as, discomfort during the procedure.. Studies have confirmed that office-based procedures using intraurethral lidocaine have resulted in less patient reported dysuria. Many endourology procedures are done under general anesthesia such as urinary stone treatments or resection of bladder tumors. There is a paucity of data regarding the use of intraurethral lidocaine at the conclusion of these procedures evaluating patient reported dysuria. We have designed a prospective, randomized, placebo controlled trial to evaluate the role of intraurethral lidocaine instillation following endourology procedures in the anesthetized patient.

NCT ID: NCT03537144 Terminated - Clinical trials for Patent Ductus Arteriosus

Acetaminophen vs Indomethacin in Treating hsPDA

Start date: June 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see if acetaminophen (Tylenol) is as effective as indomethacin in closing patent ductus arteriosus in premature infants.

NCT ID: NCT03536559 Terminated - Clinical trials for Relapsing Remitting Multiple Sclerosis

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

VISIONARY-MS
Start date: November 23, 2018
Phase: Phase 2
Study type: Interventional

The objective of this trial is to assess the efficacy and safety of CNM-Au8 as a remyelinating treatment for vision-impairing MS lesions in participants who have chronic vision impairment as a result of Relapsing-Remitting Multiple Sclerosis. The primary endpoint is to assess the efficacy and safety of CNM-Au8 as a remyelinating therapy in patients with stable RMS. The secondary endpoint is Change in Functional Composite Responder Analysis Score from Baseline to Week 24.

NCT ID: NCT03535688 Terminated - Pain Clinical Trials

D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain

Start date: March 30, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in relieving the signs and symptoms of patients with chronic lower back pain.

NCT ID: NCT03535675 Terminated - Clinical trials for Adenocarcinoma of the Prostate

Muscadine Plus (MPX) In Men With Prostate Cancer

Start date: October 30, 2018
Phase: Phase 3
Study type: Interventional

This research is being done to determine if men with rising PSA after initial therapy for localized prostate cancer who display the Alanine/Alanine SOD2 genotype of MnSOD and supplement their diet with MPX have greater decrease in PSA slope following treatment compared to men that do not supplement with MPX.